Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Coffee - Clostridium perfringens |
👶
The modulatory effect of polyphenols from green tea, oolong tea and black tea on human intestinal microbiota in vitro. Journal of food science and technology (J Food Sci Technol ) Vol: 55 Issue 1 Pages: 399-407 Pub: 2018 Jan Epub: 2017 Dec 2 Authors Sun H , Chen Y , Cheng M , Zhang X , Zheng X , Zhang Z , Html Article Publication |
| Coffee - Clostridium perfringens |
📓
Liposomal Epigallocatechin-3-Gallate for the Treatment of Intestinal Dysbiosis in Children with Autism Spectrum Disorder: A Comprehensive Review. Nutrients (Nutrients ) Vol: 15 Issue 14 Pages: Pub: 2023 Jul 24 Epub: 2023 Jul 24 Authors de la Rubia Ortí JE , Moneti C , Serrano-Ballesteros P , Castellano G , Bayona-Babiloni R , Carriquí-Suárez AB , Motos-Muñoz M , Proaño B , Benlloch M , Html Article Publication |
| Coffee - Clostridium perfringens |
👶
Influence of coffee (Coffea arabica) and galacto-oligosaccharide consumption on intestinal microbiota and the host responses. FEMS microbiology letters (FEMS Microbiol Lett ) Vol: 343 Issue 2 Pages: 161-8 Pub: 2013 Jun Epub: 2013 May 9 Authors Nakayama T , Oishi K , Publication |
| Coffee - Clostridium perfringens |
📓
Effect of tea phenolics and their aromatic fecal bacterial metabolites on intestinal microbiota. Research in microbiology (Res Microbiol ) Vol: 157 Issue 9 Pages: 876-84 Pub: 2006 Nov Epub: 2006 Aug 18 Authors Lee HC , Jenner AM , Low CS , Lee YK , Publication Publication |
| Coffee - Clostridium perfringens |
👶
Epigallocatechin gallate induces a hepatospecific decrease in the CYP3A expression level by altering intestinal flora. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences (Eur J Pharm Sci ) Vol: 100 Issue Pages: 211-218 Pub: 2017 Mar 30 Epub: 2017 Jan 21 Authors Ikarashi N , Ogawa S , Hirobe R , Kon R , Kusunoki Y , Yamashita M , Mizukami N , Kaneko M , Wakui N , Machida Y , Sugiyama K , Publication Publication |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription
All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.
Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.217 ]
Due to AI drones slamming this site, we have added IP blocking on excessive calls. Email us if you get blocked and send this [216.73.217 ]